KENDALL SMITH: Open Payments
NPI 1366936833 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,507 in 108 payments from 19 companies in 2025. Trend: 2023 $2,660 · 2024 $5,827 · 2025 $4,507
Food & beverage: $3,698Consulting: $760Education: $49
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $1,211 |
| LEO Pharma Inc. | 12 | $572 |
| Galderma Laboratories, L.P. | 10 | $401 |
| ABBVIE INC. | 16 | $362 |
| Arcutis Biotherapeutics, Inc. | 11 | $339 |
| Janssen Biotech, Inc. | 8 | $306 |
| Incyte Corporation | 6 | $291 |
| Organon LLC | 7 | $243 |
| Regeneron Healthcare Solutions, Inc. | 10 | $204 |
| Amgen Inc. | 3 | $163 |
Products named: Bimzelx, NEMLUVIO, ADBRY, TREMFYA, OPZELURA, SKYRIZI, DUPIXENT, ANZUPGO.
Industry payments across AZ — which companies pay providers there.
